Stoke Therapeutics, Inc. (STOK)

SEC filing

Stoke Therapeutics, Inc.

STOK · CIK 1623526

4 · Aug 18, 2026 · Kaye Edward M. MD sold 12.57K shares at $32.03/share ($402.5K); exercised options for 26.25K shares

Kaye Edward M. MD sold 12.57K shares at $32.03/share ($402.5K); exercised options for 26.25K shares

xslF345X06/form4-08192026_120851.xml

xslF345X06/form4-08192026_120851.xmlSEC.gov

Graphics and non-inline formats (not embedded below).